Drug Standards
AdipoGen Suramin Hexasodium salt, 129-46-4, MFCD00210217, 50 mg
MF: C51H34N6O23S6 . 6Na, MW: 1429.180, ≥98%, Appearance: White to off-white powder. Potent ATPase inhibitor. Potent competitive inhibitor of reverse transcriptase. Shows anti-HIV activity. Anticancer compound. Protein kinase C (PKC) inhibitor.
Sigma Aldrich Fine Chemicals Biosciences Chenodeoxycholic acid European Pharmacopoeia (EP) Reference Standard | 474-25-9 | MFCD00064142
Chenodeoxycholic acid European Pharmacopoeia (EP) Reference Standard | MW: 392.57 | 474-25-9 | MFCD00064142
Sigma Aldrich Fine Chemicals Biosciences Sodium salicylate European Pharmacopoeia (EP) Reference Standard | 54-21-7 | MFCD00002440 |
Sodium salicylate European Pharmacopoeia (EP) Reference Standard | Mol Wt: 160.1 | 54-21-7 | MFCD00002440 |
Cayman Chemical HexnoIc AcId-d11 100mg
An internal standard for the quantification of hexanoic acid by GC- or LC-MS
Cayman Chemical HexnoIc AcId-d11 500mg
An internal standard for the quantification of hexanoic acid by GC- or LC-MS
Medchemexpress LLC Fluticasone furoate | 397864-44-7 | C27H29F3O6S | 100 MG
Fluticasone furoate is a topical, intranasal, enhanced-affinity synthetic trifluorinated corticosteroid with a Kd of 0.3 nM. It exhibits potent anti-inflammatory and anti-asthmatic activity with low systemic exposure. It has potential for allergic rhinitis treatment and effectively inhibits tumor necrosis factor synthesis and action.
- Potent anti-inflammatory and anti-asthmatic activity
- Low systemic exposure
- Potential for allergic rhinitis treatment
- Inhibits tumor necrosis factor synthesis and action
- Prevents damage to cultured human lung epithelial cells from various stimuli
Selleck Chemical LLC Nabumetone S4051-250mg
Nabumetone (BRL-14777) is a non-steroidal anti-inflammatory drug and its active metabolite inhibits the COX
Medchemexpress LLC CPD-1224 | 2891620-68-9 | C43H47ClN8O7S | 100 MG
CPD-1224 is an orally effective ALK inhibitor derived from an ALK inhibitor that connects to the cereblon ligand. It targets the EML4-ALK oncogenic fusion protein, leading to the degradation of both ALK and its mutant forms L1196M/G1202R. This compound has the potential to slow down tumor growth and is for research use only.
- Enhances kinase binding selectivity and exhibits good degradation selectivity
- Shows antiproliferative activity against mouse Ba/F3 cells
- Demonstrates oral bioavailability of 28% in mice (10 mg/kg, oral)
- Inhibits tumor growth in mice by reducing total ALK and phosphorylated ALK levels
Apexbio Technology LLC Influenza neuraminidase inhibitor. Oseltamivir acid 10mg. 155294-62-5. MFCD22665748
Influenza neuraminidase inhibitor. Oseltamivir acid 10mg. 155294-62-5. MFCD22665748
Cayman Chemical MetronIdazole ImpurIty G 50mg
A potential impurity found in commercial preparations of metronidazole; an inactive metabolite of metronidazole
Sigma Aldrich Fine Chemicals Biosciences Docetaxel trihydrate European Pharmacopoeia (EP) Reference Standard | 148408-66-6 |
Docetaxel trihydrate European Pharmacopoeia (EP) Reference Standard | Mol Wt: 861.93 | 148408-66-6 |
Sigma Aldrich Fine Chemicals Biosciences Repaglinide Related Compound E United States Pharmacopeia (USP) Reference Standard | 147852-26-4 | 20MG
Repaglinide Related Compound E United States Pharmacopeia (USP) Reference Standard | Mol Wt: 452.59 | 147852-26-4 | 20MG